|
1
|
Szczepanski AP, Tsuboyama N, Watanabe J,
Hashizume R, Zhao Z and Wang L: POU2AF2/C11orf53 functions as a
coactivator of POU2F3 by maintaining chromatin accessibility and
enhancer activity. Sci Adv. 8:eabq24032022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wang Y, Ren F, Sun D, Liu J, Liu B, He Y,
Pang S, Shi B, Zhou F, Yao L, et al: CircKEAP1 suppresses the
progression of lung adenocarcinoma via the miR-141-3p/KEAP1/NRF2
axis. Front Oncol. 11:6725862021. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yuan J, Yuan B, Zeng L, Liu B, Chen Y,
Meng X, Sun R, Lv X, Wang W and Yang S: Identification and
validation of tumor microenvironment-related genes of prognostic
value in lung adenocarcinoma. Oncol Lett. 20:1772–1780. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Soria JC, Ohe Y, Vansteenkiste J,
Reungwetwattana T, Chewaskulyong B, Lee KH, Dechaphunkul A, Imamura
F, Nogami N, Kurata T, et al: Osimertinib in untreated EGFR-mutated
advanced non-small-cell lung cancer. N Engl J Med. 378:113–125.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa
K, Mekhail T, Felip E, Cappuzzo F, Paolini J, Usari T, et al:
First-line crizotinib versus chemotherapy in ALK-positive lung
cancer. N Engl J Med. 371:2167–2177. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mazières J, Zalcman G, Crinò L, Biondani
P, Barlesi F, Filleron T, Dingemans AM, Léna H, Monnet I,
Rothschild SI, et al: Crizotinib therapy for advanced lung
adenocarcinoma and a ROS1 rearrangement: Results from the EUROS1
cohort. J Clin Oncol. 33:992–999. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miller KD, Nogueira L, Devasia T, Mariotto
AB, Yabroff KR, Jemal A, Kramer J and Siegel RL: Cancer treatment
and survivorship statistics, 2022. CA Cancer J Clin. 72:409–436.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jia H, Gao Z, Yu F, Guo H and Li B:
Actin-binding protein anillin promotes the progression of
hepatocellular carcinoma in vitro and in mice. Exp Ther Med.
21:4542021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Strausberg RL, Feingold EA, Grouse LH,
Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler
GD, Altschul SF, et al: Generation and initial analysis of more
than 15,000 full-length human and mouse cDNA sequences. Proc Natl
Acad Sci USA. 99:16899–16903. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ota T, Suzuki Y, Nishikawa T, Otsuki T,
Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, et al:
Complete sequencing and characterization of 21,243 full-length
human cDNAs. Nat Genet. 36:40–45. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lian YF, Huang YL, Wang JL, Deng MH, Xia
TL, Zeng MS, Chen MS, Wang HB and Huang YH: Anillin is required for
tumor growth and regulated by miR-15a/miR-16-1 in HBV-related
hepatocellular carcinoma. Aging (Albany NY). 10:1884–1901. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Deng F, Xu Z, Zhou J, Zhang R and Gong X:
ANLN Regulated by miR-30a-5p mediates malignant progression of lung
adenocarcinoma. Comput Math Methods Med. 2021:95492872021.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luo C, Lei M and Zhang Y, Zhang Q, Li L,
Lian J, Liu S, Wang L, Pi G and Zhang Y: Systematic construction
and validation of an immune prognostic model for lung
adenocarcinoma. J Cell Mol Med. 24:1233–1244. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Deng Y, Chen X, Huang C, Song J, Feng S,
Chen X and Zhou R: Screening and validation of significant genes
with poor prognosis in pathologic stage-I lung adenocarcinoma. J
Oncol. 2022:37940212022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang L, Luo Y, Cheng T, Chen J, Yang H,
Wen X, Jiang Z, Li H and Pan C: Development and validation of a
prognostic N6-methyladenosine-related immune gene signature for
lung adenocarcinoma. Pharmgenomics Pers Med. 14:1549–1563.
2021.PubMed/NCBI
|
|
16
|
Broz P, Pelegrin P and Shao F: The
gasdermins, a protein family executing cell death and inflammation.
Nat Rev Immunol. 20:143–157. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lin W, Chen Y, Wu B, Chen Y and Li Z:
Identification of the pyroptosis-related prognostic gene signature
and the associated regulation axis in lung adenocarcinoma. Cell
Death Discov. 7:1612021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gu H, Deng W, Zhang Y, Chang Y, Shelat VG,
Tsuchida K, Lino-Silva LS and Wang Z: NLRP3 activation in
tumor-associated macrophages enhances lung metastasis of pancreatic
ductal adenocarcinoma. Transl Lung Cancer Res. 11:858–868. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gao J, Qiu X, Xi G, Liu H, Zhang F, Lv T
and Song Y: Downregulation of GSDMD attenuates tumor proliferation
via the intrinsic mitochondrial apoptotic pathway and inhibition of
EGFR/Akt signaling and predicts a good prognosis in non-small cell
lung cancer. Oncol Rep. 40:1971–1984. 2018.PubMed/NCBI
|
|
20
|
Wang Y, Kong H, Zeng X, Liu W, Wang Z, Yan
X, Wang H and Xie W: Activation of NLRP3 inflammasome enhances the
proliferation and migration of A549 lung cancer cells. Oncol Rep.
35:2053–2064. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dai X, Chen X, Hakizimana O and Mei Y:
Genetic interactions between ANLN and KDR are prognostic for breast
cancer survival. Oncol Rep. 42:2255–2266. 2019.PubMed/NCBI
|
|
22
|
Wang Y, Zhang JW, Wang JW, Wang JL, Zhang
SC, Ma RY, Zhang J, Li Y, Liu PJ, Xue WJ, et al: BMSCs
overexpressed ISL1 reduces the apoptosis of islet cells through
ANLN carrying exosome, INHBA, and caffeine. Cell Mol Life Sci.
79:5382022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Harrison PT, Vyse S and Huang PH: Rare
epidermal growth factor receptor (EGFR) mutations in non-small cell
lung cancer. Semin Cancer Biol. 61:167–179. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Muller IB, de Langen AJ, Giovannetti E and
Peters GJ: Anaplastic lymphoma kinase inhibition in metastatic
non-small cell lung cancer: Clinical impact of alectinib. Onco
Targets Ther. 10:4535–4541. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Drilon A, Wang L, Hasanovic A, Suehara Y,
Lipson D, Stephens P, Ross J, Miller V, Ginsberg M, Zakowski MF, et
al: Response to Cabozantinib in patients with RET fusion-positive
lung adenocarcinomas. Cancer Discov. 3:630–635. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bergethon K, Shaw AT, Ou SH, Katayama R,
Lovly CM, McDonald NT, Massion PP, Siwak-Tapp C, Gonzalez A, Fang
R, et al: ROS1 rearrangements define a unique molecular class of
lung cancers. J Clin Oncol. 30:863–870. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tan AC and Tan DSW: Targeted therapies for
lung cancer patients with oncogenic driver molecular alterations. J
Clin Oncol. 40:611–625. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hall G, Lane BM, Khan K, Pediaditakis I,
Xiao J, Wu G, Wang L, Kovalik ME, Chryst-Stangl M, Davis EE, et al:
The human FSGS-causing ANLN R431C mutation induces dysregulated
PI3K/AKT/mTOR/Rac1 signaling in podocytes. J Am Soc Nephrol.
29:2110–2122. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shi Y, Ma X, Wang M, Lan S, Jian H, Wang
Y, Wei Q and Zhong F: Comprehensive analyses reveal the
carcinogenic and immunological roles of ANLN in human cancers.
Cancer Cell Int. 22:1882022. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Y, Chen L, Ju L, Qian K, Liu X, Wang
X and Xiao Y: Novel biomarkers associated with progression and
prognosis of bladder cancer identified by co-expression analysis.
Front Oncol. 9:10302019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang F, Cai J, Hu K, Liu W, Lu S, Tang B,
Li M, Wu W, Ren Z and Yin X: An immune-related gene signature
predicting prognosis and immunotherapy response in hepatocellular
carcinoma. Comb Chem High Throughput Screen. 25:2203–2216. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang G, Shen W, Cui L, Chen W, Hu X and Fu
J: Overexpression of Anillin (ANLN) is correlated with colorectal
cancer progression and poor prognosis. Cancer Biomark. 16:459–465.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guo E, Mao X, Wang X, Guo L, An C, Zhang
C, Song K, Wang G, Duan C, Zhang X, et al: Alternatively spliced
ANLN isoforms synergistically contribute to the progression of head
and neck squamous cell carcinoma. Cell Death Dis. 12:7642021.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu Y, Cao P, Cao F, Wang S, He Y, Xu Y
and Wang Y: ANLN, regulated by SP2, promotes colorectal carcinoma
cell proliferation via PI3K/AKT and MAPK signaling pathway. J
Invest Surg. 35:268–277. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wang Z, Hu S, Li X, Liu Z, Han D, Wang Y,
Wei L, Zhang G and Wang X: MiR-16-5p suppresses breast cancer
proliferation by targeting ANLN. BMC Cancer. 21:11882021.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yu P, Zhang X, Liu N, Tang L, Peng C and
Chen X: Pyroptosis: Mechanisms and diseases. Signal Transduct
Target Ther. 6:1282021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Man SM and Kanneganti TD: Converging roles
of caspases in inflammasome activation, cell death and innate
immunity. Nat Rev Immunol. 16:7–21. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Brocker CN, Kim D, Melia T, Karri K,
Velenosi TJ, Takahashi S, Aibara D, Bonzo JA, Levi M, Waxman DJ and
Gonzalez FJ: Long non-coding RNA Gm15441 attenuates hepatic
inflammasome activation in response to PPARA agonism and fasting.
Nat Commun. 11:58472020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tsuchiya K, Nakajima S, Hosojima S, Thi
Nguyen D, Hattori T, Manh Le T, Hori O, Mahib MR, Yamaguchi Y,
Miura M, et al: Caspase-1 initiates apoptosis in the absence of
gasdermin D. Nat Commun. 10:20912019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Paik S, Kim JK, Silwal P, Sasakawa C and
Jo EK: An update on the regulatory mechanisms of NLRP3 inflammasome
activation. Cell Mol Immunol. 18:1141–1160. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Looi CK, Hii LW, Chung FF, Mai CW, Lim WM
and Leong CO: Roles of inflammasomes in Epstein-Barr
virus-associated nasopharyngeal cancer. Cancers (Basel).
13:17862021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Shi J, Zhao Y, Wang K, Shi X, Wang Y,
Huang H, Zhuang Y, Cai T, Wang F and Shao F: Cleavage of GSDMD by
inflammatory caspases determines pyroptotic cell death. Nature.
526:660–665. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Evavold CL, Hafner-Bratkovič I, Devant P,
D'Andrea JM, Ngwa EM, Boršić E, Doench JG, LaFleur MW, Sharpe AH,
Thiagarajah JR and Kagan JC: Control of gasdermin D oligomerization
and pyroptosis by the Ragulator-Rag-mTORC1 pathway. Cell.
184:4495–4511.e19. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
de Vasconcelos NM, Van Opdenbosch N, Van
Gorp H, Parthoens E and Lamkanfi M: Single-cell analysis of
pyroptosis dynamics reveals conserved GSDMD-mediated subcellular
events that precede plasma membrane rupture. Cell Death Differ.
26:146–161. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Xi H, Zhang Y, Xu Y, Yang WY, Jiang X, Sha
X, Cheng X, Wang J, Qin X, Yu J, et al: Caspase-1 inflammasome
activation mediates homocysteine-induced pyrop-apoptosis in
endothelial cells. Circ Res. 118:1525–1539. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang MY, Jiang YX, Yang YC, Liu JY, Huo
C, Ji XL and Qu YQ: Cigarette smoke extract induces pyroptosis in
human bronchial epithelial cells through the ROS/NLRP3/caspase-1
pathway. Life Sci. 269:1190902021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Fu X, Hong W, Li S, Chen Z, Zhou W, Dai J,
Deng X, Zhou H, Li B and Ran P: Wood smoke particulate matter
(WSPM2.5) induces pyroptosis through both caspase-1/IL-1β/IL-18 and
ATP/P2Y-dependent mechanisms in human bronchial epithelial cells.
Chemosphere. 307:1357262022. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kayagaki N, Wong MT, Stowe IB, Ramani SR,
Gonzalez LC, Akashi-Takamura S, Miyake K, Zhang J, Lee WP,
Muszyński A, et al: Noncanonical inflammasome activation by
intracellular LPS independent of TLR4. Science. 341:1246–1249.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Knodler LA, Crowley SM, Sham HP, Yang H,
Wrande M, Ma C, Ernst RK, Steele-Mortimer O, Celli J and Vallance
BA: Noncanonical inflammasome activation of caspase-4/caspase-11
mediates epithelial defenses against enteric bacterial pathogens.
Cell Host Microbe. 16:249–256. 2014. View Article : Google Scholar : PubMed/NCBI
|
